File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1159/000186527
- Scopus: eid_2-s2.0-0025788538
- PMID: 1944720
- WOS: WOS:A1991GB77600020
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis
Title | Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis |
---|---|
Authors | |
Keywords | Continuous ambulatory peritoneal dialysis Phosphatidylcholine Solute transfer Ultrafiltration |
Issue Date | 1991 |
Publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/NEF |
Citation | Nephron, 1991, v. 59 n. 1, p. 100-103 How to Cite? |
Abstract | Oral phosphatidylcholine at 900 mg/day was given to 4 patients with high lymph absorption for 8 weeks. Fluid and solute transfer before and after treatment were compared to 4 similar controls given placebo. None of the patients had overt ultrafiltration problems. After treatment, overnight peritoneal effluent phospholipid content did not change significantly. Ultrafiltration as well as solute and glucose transfer remained unchanged at the end of 8 weeks. A controlled trial on patients with overt ultrafiltration problems for a longer duration is required to further elucidate the role of phosphatidylcholine supplementation in patients on continuous ambulatory peritoneal dialysis. |
Persistent Identifier | http://hdl.handle.net/10722/161867 |
ISSN | 2023 SCImago Journal Rankings: 0.774 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, PCK | en_US |
dc.contributor.author | Tam, SCF | en_US |
dc.contributor.author | Robinson, JD | en_US |
dc.contributor.author | Yu, L | en_US |
dc.contributor.author | Ip, MSM | en_US |
dc.contributor.author | Chan, CY | en_US |
dc.contributor.author | Cheng, IKP | en_US |
dc.date.accessioned | 2012-09-05T05:15:38Z | - |
dc.date.available | 2012-09-05T05:15:38Z | - |
dc.date.issued | 1991 | en_US |
dc.identifier.citation | Nephron, 1991, v. 59 n. 1, p. 100-103 | en_US |
dc.identifier.issn | 0028-2766 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/161867 | - |
dc.description.abstract | Oral phosphatidylcholine at 900 mg/day was given to 4 patients with high lymph absorption for 8 weeks. Fluid and solute transfer before and after treatment were compared to 4 similar controls given placebo. None of the patients had overt ultrafiltration problems. After treatment, overnight peritoneal effluent phospholipid content did not change significantly. Ultrafiltration as well as solute and glucose transfer remained unchanged at the end of 8 weeks. A controlled trial on patients with overt ultrafiltration problems for a longer duration is required to further elucidate the role of phosphatidylcholine supplementation in patients on continuous ambulatory peritoneal dialysis. | en_US |
dc.language | eng | en_US |
dc.publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/NEF | en_US |
dc.relation.ispartof | Nephron | en_US |
dc.subject | Continuous ambulatory peritoneal dialysis | - |
dc.subject | Phosphatidylcholine | - |
dc.subject | Solute transfer | - |
dc.subject | Ultrafiltration | - |
dc.subject.mesh | Absorption | en_US |
dc.subject.mesh | Administration, Oral | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Kidney Failure, Chronic - Drug Therapy - Physiopathology - Therapy | en_US |
dc.subject.mesh | Lipids - Blood | en_US |
dc.subject.mesh | Lymph - Drug Effects - Physiology | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Peritoneal Dialysis, Continuous Ambulatory - Adverse Effects | en_US |
dc.subject.mesh | Phosphatidylcholines - Administration & Dosage - Therapeutic Use | en_US |
dc.title | Effect of phosphatidylcholine on ultrafiltration in patients on continuous ambulatory peritoneal dialysis | en_US |
dc.type | Article | en_US |
dc.identifier.email | Ip, MSM:msmip@hku.hk | en_US |
dc.identifier.authority | Ip, MSM=rp00347 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1159/000186527 | - |
dc.identifier.pmid | 1944720 | - |
dc.identifier.scopus | eid_2-s2.0-0025788538 | en_US |
dc.identifier.volume | 59 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.spage | 100 | en_US |
dc.identifier.epage | 103 | en_US |
dc.identifier.isi | WOS:A1991GB77600020 | - |
dc.publisher.place | Switzerland | en_US |
dc.identifier.scopusauthorid | Chan, PCK=7403497841 | en_US |
dc.identifier.scopusauthorid | Tam, SCF=7202037323 | en_US |
dc.identifier.scopusauthorid | Robinson, JD=7405867967 | en_US |
dc.identifier.scopusauthorid | Yu, L=8617704200 | en_US |
dc.identifier.scopusauthorid | Ip, MSM=7102423259 | en_US |
dc.identifier.scopusauthorid | Chan, CY=24517697500 | en_US |
dc.identifier.scopusauthorid | Cheng, IKP=7102537483 | en_US |
dc.identifier.issnl | 0028-2766 | - |